The Italian nervous system medicine market, valued at 3.5 billion USD PPP in 2024, shows steady growth with year-on-year increases: 4.57% to 2025, 4.10% to 2026, and 4.20% to 2027. The five-year compound annual growth rate (CAGR) stands at approximately 4.10%, reflecting a consistent upward trend from 2023, when the market was valued at 3.35 billion USD PPP.

Future trends to watch for:

The impact of technological advancements and innovations in drug development.
Changes in healthcare policies and funding affecting the accessibility and affordability of nervous system medicines.
The role of aging demographics in increasing the demand for neurological treatments.